166 related articles for article (PubMed ID: 22796099)
21. Are antidepressant drugs that combine serotonergic and noradrenergic mechanisms of action more effective than the selective serotonin reuptake inhibitors in treating major depressive disorder? A meta-analysis of studies of newer agents.
Papakostas GI; Thase ME; Fava M; Nelson JC; Shelton RC
Biol Psychiatry; 2007 Dec; 62(11):1217-27. PubMed ID: 17588546
[TBL] [Abstract][Full Text] [Related]
22. Edivoxetine compared to placebo as adjunctive therapy to selective serotonin reuptake inhibitors in the prevention of symptom re-emergence in major depressive disorder.
Oakes TM; Dellva MA; Waterman K; Greenbaum M; Poppe C; Goldberger C; Ahl J; Perahia DG
Curr Med Res Opin; 2015 Jun; 31(6):1179-89. PubMed ID: 25894953
[TBL] [Abstract][Full Text] [Related]
23. Evidence of involvement of the human Par-4 (PAWR) gene in major depressive disorder.
Liou YJ; Chen TJ; Tsai SJ; Yu YW; Chen SY; Cheng CY; Hong CJ
World J Biol Psychiatry; 2011 Jun; 12(4):288-95. PubMed ID: 20735158
[TBL] [Abstract][Full Text] [Related]
24. Association of the TLR4 gene with depressive symptoms and antidepressant efficacy in major depressive disorder.
Wang J; Yang C; Liu Z; Li X; Liu M; Wang Y; Zhang K; Sun N
Neurosci Lett; 2020 Sep; 736():135292. PubMed ID: 32763359
[TBL] [Abstract][Full Text] [Related]
25. Serotonin receptor 2A gene polymorphism (-1438A/G) and short-term treatment response to citalopram.
Choi MJ; Kang RH; Ham BJ; Jeong HY; Lee MS
Neuropsychobiology; 2005; 52(3):155-62. PubMed ID: 16127283
[TBL] [Abstract][Full Text] [Related]
26. Association study of corticotropin-releasing hormone receptor1 gene polymorphisms and antidepressant response in major depressive disorders.
Liu Z; Zhu F; Wang G; Xiao Z; Tang J; Liu W; Wang H; Liu H; Wang X; Wu Y; Cao Z; Li W
Neurosci Lett; 2007 Mar; 414(2):155-8. PubMed ID: 17258395
[TBL] [Abstract][Full Text] [Related]
27. Klotho Gene and Selective Serotonin Reuptake Inhibitors: Response to Treatment in Late-Life Major Depressive Disorder.
Paroni G; Seripa D; Fontana A; D'Onofrio G; Gravina C; Urbano M; Addante F; Lozupone M; Copetti M; Pilotto A; Greco A; Panza F
Mol Neurobiol; 2017 Mar; 54(2):1340-1351. PubMed ID: 26843110
[TBL] [Abstract][Full Text] [Related]
28. 5-HT2A receptor -1438 G/A polymorphism and serotonergic antidepressant-induced sexual dysfunction in male patients with major depressive disorder: a prospective exploratory study.
Liang CS; Ho PS; Chiang KT; Su HC
J Sex Med; 2012 Aug; 9(8):2009-16. PubMed ID: 22612784
[TBL] [Abstract][Full Text] [Related]
29. Monoamine transporter gene polymorphisms and antidepressant response in koreans with late-life depression.
Kim H; Lim SW; Kim S; Kim JW; Chang YH; Carroll BJ; Kim DK
JAMA; 2006 Oct; 296(13):1609-18. PubMed ID: 17018806
[TBL] [Abstract][Full Text] [Related]
30. Association between -1438G/A promoter polymorphism in the 5-HT(2A) receptor gene and fluvoxamine response in Japanese patients with major depressive disorder.
Sato K; Yoshida K; Takahashi H; Ito K; Kamata M; Higuchi H; Shimizu T; Itoh K; Inoue K; Tezuka T; Suzuki T; Ohkubo T; Sugawara K; Otani K
Neuropsychobiology; 2002; 46(3):136-40. PubMed ID: 12422060
[TBL] [Abstract][Full Text] [Related]
31. Systems genetics analysis of pharmacogenomics variation during antidepressant treatment.
Madsen MB; Kogelman LJA; Kadarmideen HN; Rasmussen HB
Pharmacogenomics J; 2018 Jan; 18(1):144-152. PubMed ID: 27752142
[TBL] [Abstract][Full Text] [Related]
32. HTR2A gene variation is involved in antidepressant treatment response.
Lucae S; Ising M; Horstmann S; Baune BT; Arolt V; Müller-Myhsok B; Holsboer F; Domschke K
Eur Neuropsychopharmacol; 2010 Jan; 20(1):65-8. PubMed ID: 19758789
[TBL] [Abstract][Full Text] [Related]
33. Genetic predictors of response to serotonergic and noradrenergic antidepressants in major depressive disorder: a genome-wide analysis of individual-level data and a meta-analysis.
Tansey KE; Guipponi M; Perroud N; Bondolfi G; Domenici E; Evans D; Hall SK; Hauser J; Henigsberg N; Hu X; Jerman B; Maier W; Mors O; O'Donovan M; Peters TJ; Placentino A; Rietschel M; Souery D; Aitchison KJ; Craig I; Farmer A; Wendland JR; Malafosse A; Holmans P; Lewis G; Lewis CM; Stensbøl TB; Kapur S; McGuffin P; Uher R
PLoS Med; 2012; 9(10):e1001326. PubMed ID: 23091423
[TBL] [Abstract][Full Text] [Related]
34. Antidepressant response and intolerance to SSRI is not influenced by G-protein beta3 subunit gene C825T polymorphism in Japanese major depressive patients.
Kato M; Wakeno M; Okugawa G; Fukuda T; Takekita Y; Hosoi Y; Azuma J; Kinoshita T; Serretti A
Prog Neuropsychopharmacol Biol Psychiatry; 2008 May; 32(4):1041-4. PubMed ID: 18325652
[TBL] [Abstract][Full Text] [Related]
35. No association of TPH1 218A/C polymorphism with treatment response and intolerance to SSRIs in Japanese patients with major depression.
Kato M; Wakeno M; Okugawa G; Fukuda T; Azuma J; Kinoshita T; Serretti A
Neuropsychobiology; 2007; 56(4):167-71. PubMed ID: 18332644
[TBL] [Abstract][Full Text] [Related]
36. Female sexual dysfunction in patients with major depressive disorder (MDD) treated with selective serotonin reuptake inhibitor (SSRI) and its association with serotonin 2A-1438 G/A single nucleotide polymorphisms.
Masiran R; Sidi H; Mohamed Z; Mohd Nazree NE; Nik Jaafar NR; Midin M; Das S; Mohamed Saini S
J Sex Med; 2014 Apr; 11(4):1047-1055. PubMed ID: 24533444
[TBL] [Abstract][Full Text] [Related]
37. Influence and interaction of genetic polymorphisms in the serotonin system and life stress on antidepressant drug response.
Xu Z; Zhang Z; Shi Y; Pu M; Yuan Y; Zhang X; Li L; Reynolds GP
J Psychopharmacol; 2012 Mar; 26(3):349-59. PubMed ID: 21937687
[TBL] [Abstract][Full Text] [Related]
38. Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response.
Li QS; Tian C; Seabrook GR; Drevets WC; Narayan VA
Transl Psychiatry; 2016 Sep; 6(9):e889. PubMed ID: 27622933
[TBL] [Abstract][Full Text] [Related]
39. Role of the serotonin transporter gene locus in the response to SSRI treatment of major depressive disorder in late life.
Seripa D; Pilotto A; Paroni G; Fontana A; D'Onofrio G; Gravina C; Urbano M; Cascavilla L; Paris F; Panza F; Padovani A; Pilotto A
J Psychopharmacol; 2015 May; 29(5):623-33. PubMed ID: 25827644
[TBL] [Abstract][Full Text] [Related]
40. Influence of BCL2 gene in major depression susceptibility and antidepressant treatment outcome.
Zhang C; Wu Z; Hong W; Wang Z; Peng D; Chen J; Yuan C; Yu S; Xu L; Fang Y
J Affect Disord; 2014 Feb; 155():288-94. PubMed ID: 24321200
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
